199 related articles for article (PubMed ID: 17630552)
21. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
Lingappa JR; Kahle E; Mugo N; Mujugira A; Magaret A; Baeten J; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife K; Debruyn G; Gray G; McIntyre J; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Coombs RW; Morrow R; Whittington W; Corey L; Wald A; Celum C;
PLoS One; 2009; 4(4):e5272. PubMed ID: 19404392
[TBL] [Abstract][Full Text] [Related]
22. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India.
Khopkar P; Sane S; Bichare S; Verma A; Kulkarni S
J Clin Virol; 2013 Dec; 58(4):730-2. PubMed ID: 24238888
[TBL] [Abstract][Full Text] [Related]
23. Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.
Bender Ignacio RA; Perti T; Magaret AS; Rajagopal S; Stevens CE; Huang ML; Selke S; Johnston C; Marrazzo J; Wald A
J Infect Dis; 2015 Dec; 212(12):1949-56. PubMed ID: 26044291
[TBL] [Abstract][Full Text] [Related]
24. Genital HSV-1 DNA detection is associated with a low inflammatory profile in HIV-uninfected South African women.
Mtshali A; Ngcapu S; Osman F; Garrett N; Singh R; Rompalo A; Mindel A; Liebenberg LJP
Sex Transm Infect; 2021 Feb; 97(1):33-37. PubMed ID: 32848051
[TBL] [Abstract][Full Text] [Related]
25. Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.
Mbopi-Kéou FX; Bélec L; Dalessio J; Legoff J; Grésenguet G; Mayaud P; Brown DW; Morrow RA
Clin Diagn Lab Immunol; 2003 May; 10(3):388-93. PubMed ID: 12738636
[TBL] [Abstract][Full Text] [Related]
26. High Rate of β-Globin DNA Detection Validates Self-Sampling in Herpes Simplex Virus Shedding Studies.
Mujugira A; Huang ML; Selke S; Drolette L; Magaret AS; Wald A
Sex Transm Dis; 2015 Dec; 42(12):705-9. PubMed ID: 26562701
[TBL] [Abstract][Full Text] [Related]
27. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
28. Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Roxby AC; Drake AL; Ongecha-Owuor F; Kiarie JN; Richardson B; Matemo DN; Overbaugh J; Emery S; John-Stewart GC; Wald A; Farquhar C
PLoS One; 2012; 7(6):e38622. PubMed ID: 22701683
[TBL] [Abstract][Full Text] [Related]
29. Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.
Mitchell C; Balkus JE; McKernan-Mullin J; Cohn SE; Luque AE; Mwachari C; Cohen CR; Coombs R; Frenkel LM; Hitti J
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):143-8. PubMed ID: 23018377
[TBL] [Abstract][Full Text] [Related]
30. Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.
Barnabas RV; Celum C
Curr HIV Res; 2012 Apr; 10(3):228-37. PubMed ID: 22384842
[TBL] [Abstract][Full Text] [Related]
31. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
33. Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.
Ford ES; Magaret AS; Spak CW; Selke S; Kuntz S; Corey L; Wald A
AIDS; 2018 Nov; 32(17):2525-2531. PubMed ID: 30289810
[TBL] [Abstract][Full Text] [Related]
34. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
Nelson JAE; De Paris K; Ramirez C; Edmonds A; Mollan KR; Bay CP; Compliment K; Herold BC; Anastos K; Minkoff H; Kassaye S; Seidman DL; French AL; Golub ET; Sheth AN; Ochsenbauer C; Swanstrom R; Eron JJ; Adimora AA
AIDS; 2020 Jan; 34(1):39-46. PubMed ID: 31483374
[TBL] [Abstract][Full Text] [Related]
35. Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
Agyemang E; Magaret AS; Selke S; Johnston C; Corey L; Wald A
J Infect Dis; 2018 Oct; 218(11):1691-1699. PubMed ID: 30020484
[TBL] [Abstract][Full Text] [Related]
36. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.
Low AJ; Konate I; Nagot N; Weiss HA; Kania D; Vickerman P; Segondy M; Mabey D; Pillay D; Meda N; van de Perre P; Mayaud P;
J Acquir Immune Defic Syndr; 2014 Feb; 65(2):237-45. PubMed ID: 24226060
[TBL] [Abstract][Full Text] [Related]
37. Brief Report: Herpes Simplex Virus Type-2 Shedding and Genital Ulcers During Early HIV in Zimbabwean Women.
Nowak RG; Liska TA; Bentzen SM; Kim E; Chipato T; Salata RA; Celentano DD; Morrison CS; Gravitt PE
J Acquir Immune Defic Syndr; 2021 Jun; 87(2):789-793. PubMed ID: 33587502
[TBL] [Abstract][Full Text] [Related]
38. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.
Watson-Jones D; Weiss HA; Rusizoka M; Changalucha J; Baisley K; Mugeye K; Tanton C; Ross D; Everett D; Clayton T; Balira R; Knight L; Hambleton I; Le Goff J; Belec L; Hayes R; ;
N Engl J Med; 2008 Apr; 358(15):1560-71. PubMed ID: 18337596
[TBL] [Abstract][Full Text] [Related]
39. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency.
John GC; Nduati RW; Mbori-Ngacha D; Overbaugh J; Welch M; Richardson BA; Ndinya-Achola J; Bwayo J; Krieger J; Onyango F; Kreiss JK
J Infect Dis; 1997 Jan; 175(1):57-62. PubMed ID: 8985196
[TBL] [Abstract][Full Text] [Related]
40. Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women.
Redd AD; Newell K; Patel EU; Nalugoda F; Ssebbowa P; Kalibbala S; Frank MA; Tobian AA; Gray RH; Quinn TC; Serwadda D; Reynolds SJ
Sex Transm Infect; 2015 Nov; 91(7):485-8. PubMed ID: 25904747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
